Impact of Providing Medical Records in a Patient-Centered, Community Pharmacy Based, HIV Care Model (HIV-MOI)
Key facts
- Who runs it
- University of North Texas Health Science Center
- Where
- Fort Worth, United StatesSee the 2 sites
- Trial code
- Status
- Terminated
- People taking part
- 129 people enrolled
- Started
- 3 Aug 2018
- Ended
- 27 Feb 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Medication optimization intervention
- Record updated
- 18 July 2025
- Why it stopped
- Recruitment and funding challenges
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- 18 years of age or older
- African-American
- HIV positive
- At least one of the following: hypertension or diabetes type 2
Who cannot take part
- Have a life expectancy < 2 years
- Pregnant (at screening, may enroll 6 months post-delivery)
- Refusal to provide medical record release
Where in United States
- Crystal HodgeFort Worth, United States
- University of North Texas Health Science CenterFort Worth, United States
About the trial
What the trial wants to find out
This is a clinical trial. The purpose of this clinical trial is to see if study participants have better health outcomes if their pharmacist has access to their medical records. The study will take place primarily in Fort Worth and Dallas, Texas. The trial will enroll adult, African-Americans with HIV. Study participants must also have either diabetes, high blood pressure or they may have both. Study participants will agree to have their medical records from all of their health providers released to UNTHSC. UNTHSC will provide the study pharmacist the medical records for half of the participants. Using the medical records, the study pharmacist will provide 'enhanced' patient counseling services to half of the participants. This enhanced service is called 'medication optimization'. For half of the participants that the study pharmacist does not see the medical records, they will receive usual and customary patient counseling. Not seeing the medical records is considered standard of care. In both groups, the counseling frequency will be based on the participant's needs but the study pharmacist will contact every participant to check on them at least every 90 days. These visits will happen for 2 years. The two groups will be compared to see if those participants having medical information supported medication optimization have better health than those getting routine, the standard of care medication optimization.
The 2 groups in the trial
- Medication Optimization InterventionTreatment being tested
This group will represent those participants whose medical records have been provided to the pharmacist.
- Medication Optimization ControlExisting treatment, for comparison
This group will represent those participants whose medical records have not been provided to the pharmacist.
Treatment: Medication optimization intervention
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessing the Impact of Providing Pharmacists With Medical Records in a Patient-Centered, Community Pharmacy-Based, HIV Care Model
- Record updated
- 18 July 2025